Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Oncolytics Biotech Inc. (T.ONC) had Return on Tangible Equity of -530.00% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-23.14M |
|
-- |
|
-- |
|
-- |
|
-24.82M |
|
-- |
|
-23.04M |
|
-23.04M |
|
-23.14M |
|
-23.14M |
|
-23.14M |
|
-23.14M |
|
-24.82M |
|
-24.51M |
|
76.48M |
|
76.48M |
|
-0.30 |
|
-0.30 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.73M |
|
-- |
|
-- |
|
-- |
|
10.36M |
|
4.37M |
|
4.37M |
|
4.37M |
|
80.02M |
|
| Cash Flow Statement Financials | |
-19.68M |
|
-0.17M |
|
4.84M |
|
25.47M |
|
11.63M |
|
-13.84M |
|
1.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.82 |
|
-- |
|
-- |
|
0.12 |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.85M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-530.00% |
|
|
Return on Tangible Equity |
-530.00% |
-157.08% |
|
-468.39% |
|
0.07 |
|
-0.26 |
|
-0.26 |
|